Our findings demonstrated that the activation of PPARγ could regulate M1/M2 macrophage polarization via the STAT‐1/STAT‐6 pathway both in vitro and in vivo, thereby attenuating the symptoms of IBD. Here, PPARG is linked to inflammatory bowel disease.